Bleeding Iritis - Causes, Treatment & When to See a Doctor

What is Bleeding Iritis?

Iritis (also called anterior uveitis) is inflammation of the iris—the colored part of the eye—and the surrounding tissues of the anterior uveal tract. When this inflammation is accompanied by bleeding, it is often described as bleeding iritis or hemorrhagic iritis. Blood may appear in the anterior chamber (the fluid‑filled space between the cornea and the iris), on the surface of the iris, or as fine pigmented cells that look like rust‑colored flakes. The presence of blood signals a more aggressive or complicated inflammatory process and usually warrants prompt evaluation.

Bleeding iritis can cause sudden visual changes, pain, and photophobia (light sensitivity). It may be isolated or a manifestation of a systemic disease such as autoimmune arthritis, infection, or trauma. Early recognition and treatment help preserve vision and prevent long‑term complications like glaucoma, cataract formation, or permanent iris damage.

Common Causes

Several ocular or systemic conditions can lead to bleeding within the anterior chamber. The most frequent culprits are:

• Traumatic injury: Penetrating or blunt eye trauma can rupture small blood vessels in the iris.
• Infectious uveitis: Bacterial (e.g., Staphylococcus aureus), viral (herpes simplex, varicella‑zoster), fungal, or parasitic (Toxoplasma) infections can cause hemorrhagic inflammation.
• Autoimmune disorders:Conditions such as ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and Behçet’s disease can produce recurrent iritis with bleeding.
• Systemic vasculitis: Granulomatosis with polyangiitis (Wegener’s) and microscopic polyangiitis can involve ocular vessels.
• Blood dyscrasias: Hemophilia, thrombocytopenia, leukemias, or other clotting‑factor deficiencies increase the risk of intra‑ocular bleeding.
• Medications: Anticoagulants (warfarin, DOACs), antiplatelet agents (aspirin, clopidogrel), and long‑term corticosteroid use can predispose to hemorrhage.
• Intra‑ocular tumors: Iris melanoma or metastatic lesions may erode vessels and bleed.
• Neovascularization: Chronic retinal ischemia (e.g., diabetic retinopathy) can stimulate new, fragile vessels that bleed into the anterior chamber.
• Post‑surgical complications: Cataract extraction, glaucoma surgery, or laser procedures can occasionally result in anterior chamber hemorrhage.
• Idiopathic: In up to 30% of cases, no clear underlying cause is identified despite thorough work‑up.

Associated Symptoms

Bleeding iritis rarely occurs in isolation. Patients often report one or more of the following alongside the presence of blood in the eye:

• Eye redness (particularly deep, circumcorneal injection)
• Sharp or dull ocular pain that worsens with eye movement
• Photophobia – extreme discomfort in bright light
• Blurred or decreased vision, sometimes described as “floating spots” (due to blood cells)
• Floaters – small dark specks drifting in the visual field
• Headache, especially if intra‑ocular pressure rises
• Tearing or watery discharge
• Feeling of “grittiness” or foreign‑body sensation
• Systemic signs (if an underlying disease is present): fever, joint pain, oral ulcers, skin lesions.

When to See a Doctor

Any new episode of eye pain, redness, or visual change should prompt a prompt eye‑care visit, but the following situations demand urgent attention:

• Sudden onset of severe eye pain.
• Rapid loss of vision or a “ curtain” appearing over part of the visual field.
• Persistent photophobia that does not improve with dim lighting.
• Presence of blood in the eye noted as a red‑brown haze in the pupil.
• History of recent eye trauma, surgery, or systemic anticoagulant use.
• Associated systemic symptoms such as fever, joint swelling, oral ulcers, or skin rashes.

Diagnosis

Evaluation of bleeding iritis combines a detailed history, a focused eye examination, and targeted investigations.

Clinical Examination

• Visual acuity testing: Determines the extent of vision loss.
• Slit‑lamp biomicroscopy: Allows the clinician to see cells, flare (protein in the aqueous humor), and blood in the anterior chamber. A “hypopyon” (layer of white cells) can coexist with blood.
• Intra‑ocular pressure (IOP) measurement: Inflammation can cause spikes in pressure that may lead to glaucoma.
• Fundus examination: Dilated view of the retina to rule out posterior segment disease.
• Pupillary reaction testing: Checks for relative afferent pupillary defect (RAPD) which can suggest optic nerve involvement.

Laboratory & Imaging Studies

• Complete blood count (CBC) & coagulation profile: Detects anemia, thrombocytopenia, or clotting disorders.
• Serologic tests: HLA‑B27, rheumatoid factor, antinuclear antibodies (ANA), anti‑CCP, and specific vasculitis panels (ANCA) when autoimmune disease is suspected.
• Infectious work‑up: PCR of aqueous humor for viral DNA, syphilis serology (RPR/VDRL), TB interferon‑gamma release assay, or toxoplasma IgG/IgM.
• Ultrasound B‑scan: Helpful if the view of the posterior segment is obscured by hemorrhage.
• Anterior segment optical coherence tomography (AS‑OCT): Provides high‑resolution images of the iris, angle, and any fluid collections.

Treatment Options

Therapy aims to control inflammation, stop bleeding, prevent complications, and restore vision. Treatment is individualized based on cause, severity, and patient comorbidities.

Medical Management

• Topical corticosteroids: Prednisolone acetate 1% or difluprednate 0.05% are first‑line to reduce iris inflammation. Tapering schedule is guided by response.
• Cycloplegic agents: Homatropine or cyclopentolate relax the iris sphincter, relieve pain, and prevent posterior synechiae (adhesions).
• IOP‑lowering drops: If pressure rises, agents such as timolol, brimonidine, or prostaglandin analogues are added. In acute spikes, oral acetazolamide may be used.
• Systemic therapy:
  • Oral corticosteroids (e.g., prednisone 0.5 mg/kg) for severe or bilateral cases, or when topical therapy is insufficient.
  • Immunosuppressive agents (methotrexate, mycophenolate mofetil, azathioprine) for chronic autoimmune uveitis.
  • Biologic agents (adalimumab, infliximab) in refractory Behçet’s disease or HLA‑B27 associated uveitis.
• Antimicrobial therapy: Targeted antibiotics, antivirals, or antifungals based on identified infection (e.g., oral acyclovir for herpes simplex iritis).
• Correction of coagulopathy: Temporary hold or dose adjustment of anticoagulants, vitamin K or fresh frozen plasma for warfarin‑related bleeding, platelet transfusion if thrombocytopenic.

Procedural Interventions

• Anterior chamber paracentesis: Small needle aspiration of blood to clear the visual axis and reduce pressure.
• Laser iridotomy: If angle closure contributes to bleeding, creating a peripheral opening can alleviate pressure.
• Surgical evacuation: Rarely required; performed by a vitreoretinal surgeon when massive hemorrhage persists.

Home & Supportive Care

• Apply cold compresses to the eyelids for pain relief (15 minutes, several times daily).
• Avoid bright lights; wear sunglasses with UV protection.
• Use lubricating artificial tears to reduce surface irritation.
• Adhere strictly to medication schedules; never stop steroids abruptly.
• Maintain good systemic control of underlying diseases (e.g., diabetes, hypertension).

Prevention Tips

While not all episodes can be avoided, the following measures reduce risk:

• Wear protective eyewear during sports, construction work, or any activity with a risk of eye injury.
• Manage systemic autoimmune conditions with regular rheumatology follow‑up and medication adherence.
• Control blood‑sugar and blood‑pressure levels to prevent retinal ischemia and neovascularization.
• If you take anticoagulants, have regular INR checks (for warfarin) and discuss any eye symptoms promptly with your clinician.
• Avoid unnecessary eye rubbing, which can traumatize fragile iris vessels.
• Schedule routine eye exams, especially if you have a known history of uveitis or systemic disease.
• Promptly treat ocular infections; never self‑medicate with steroids without a professional diagnosis.

Emergency Warning Signs

Key Take‑aways

Bleeding iritis is a potentially sight‑threatening inflammation of the iris with accompanying hemorrhage. Prompt recognition, thorough evaluation for underlying causes, and timely treatment—often with topical steroids, cycloplegics, and IOP‑lowering agents—are essential to preserve vision. Patients with systemic autoimmune disease, blood‑clotting disorders, or recent eye trauma should be especially vigilant. When emergency warning signs appear, do not delay; urgent care can prevent permanent damage.

References:

• Mayo Clinic. “Uveitis.” accessed May 2026. https://www.mayoclinic.org
• American Academy of Ophthalmology. “Anterior Uveitis (Iritis).” 2024. https://www.aao.org
• Cleveland Clinic. “Eye Inflammation (Uveitis).” 2025. https://my.clevelandclinic.org
• National Institutes of Health. “Behçet Disease.” 2023. https://www.nhlbi.nih.gov
• World Health Organization. “Guidelines for the Management of Uveitis.” 2022.